All material subject to strictly enforced copyright laws. © 2021 Euromoney Institutional Investor PLC group
EquityABBs-Block Trades

Pet drug maker Dechra Pharma raises £134m in placing

Vet_puppy_Adobe_575x375.jpg

Dechra Pharmacuticals, the pharmaceutical company focused on pets, raised £134m in an accelerated placing on Wednesday night to strengthen its balance sheet after an M&A wave and to give it headroom for further growth and to protect against the economic headwinds of the coronavirus pandemic.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree